BTIM Corp. cut its position in AptarGroup, Inc. (NYSE:ATR) by 14.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 950,530 shares of the company’s stock after selling 154,173 shares during the period. AptarGroup comprises 1.3% of BTIM Corp.’s portfolio, making the stock its 8th largest position. BTIM Corp. owned approximately 1.52% of AptarGroup worth $69,056,000 as of its most recent SEC filing.

Separately, Eagle Asset Management raised its stake in shares of AptarGroup by 94.9% in the third quarter. Eagle Asset Management now owns 66,272 shares of the company’s stock worth $4,370,000 after buying an additional 32,262 shares during the period.

AptarGroup, Inc. (NYSE:ATR) traded down 0.81% during mid-day trading on Monday, reaching $72.31. 284,729 shares of the company’s stock traded hands. AptarGroup, Inc. has a 12 month low of $60.73 and a 12 month high of $75.96. The stock has a market capitalization of $4.52 billion and a PE ratio of 23.75. The firm’s 50-day moving average price is $70.97 and its 200 day moving average price is $69.63.

AptarGroup (NYSE:ATR) last announced its quarterly earnings results on Thursday, October 29th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.04. The firm had revenue of $586 million for the quarter, compared to analyst estimates of $590.36 million. During the same period last year, the firm posted $0.73 EPS. The business’s revenue was down 10.1% compared to the same quarter last year. Equities research analysts predict that AptarGroup, Inc. will post $3.02 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 17th. Stockholders of record on Wednesday, January 27th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend is Wednesday, February 24th.

A number of analysts recently issued reports on the stock. Zacks Investment Research lowered shares of AptarGroup from a “hold” rating to a “sell” rating in a research note on Monday, January 25th. Robert W. Baird lifted their price target on shares of AptarGroup from $75.00 to $80.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. William Blair restated an “outperform” rating on shares of AptarGroup in a research note on Wednesday, January 27th. Janney Montgomery Scott upgraded shares of AptarGroup from a “neutral” rating to a “buy” rating in a research note on Monday, December 21st. Finally, Macquarie initiated coverage on shares of AptarGroup in a research note on Tuesday, November 10th. They issued a “neutral” rating and a $72.00 price target for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $75.00.

In other news, Director King W. Harris sold 27,000 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $73.39, for a total transaction of $1,981,530.00. Following the completion of the transaction, the director now owns 206,624 shares of the company’s stock, valued at $15,164,135.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hagge sold 25,000 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $73.82, for a total transaction of $1,845,500.00. Following the transaction, the chief executive officer now directly owns 64,913 shares of the company’s stock, valued at approximately $4,791,877.66. The disclosure for this sale can be found here.

AptarGroup, Inc. is a solution provider of a range of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps, closures, aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components, which include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, as well as dropper bulbs and disposable syringe plungers. The Company’s segments include Beauty + Home, Pharma and Food + Beverage.

12 Month Chart for NYSE:ATR

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related companies with MarketBeat.com's FREE daily email newsletter.